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Abstract
Objectives: The objectives were to determine the frequency of administration of potentially inappropri-
ate medications (PIMs) to older emergency department (ED) patients and to examine recent trends in the
rates of PIM usage.
Methods: The data examined during the study were obtained from the National Hospital Ambulatory
Medical Care Survey (NHAMCS). This study utilized the nationally representative ED data from 2000–
2006 NHAMCS surveys. Our sample included older adults (age 65 years and greater) who were treated
in the ED and discharged home. Estimated frequencies of PIM-associated ED visits were calculated. A
multivariable logistic regression model was created to assess demographic, clinical, and hospital factors
associated with PIM administration and to assess temporal trends.
Results: Approximately 19.5 million patients, or 16.8% (95% confidence interval [CI] = 16.1% to 17.4%)
of eligible ED visits, were associated with one or more PIMs. The five most common PIMs were pro-
methazine, ketorolac, propoxyphene, meperidine, and diphenhydramine. The total number of medica-
tions prescribed or administered during the ED visit was most strongly associated with PIM use. Other
covariates associated with PIM use included rural location outside of the Northeast, being seen by a staff
physician only (and not by a resident or intern), presenting with an injury, and the combination of
female sex and age 65–74 years. There was a small but significant decrease in the proportion of visits
associated with a PIM over the study period.
Conclusions: Potentially inappropriate medication administration in the ED remains common. Given ris-
ing concerns about preventable complications of medical care, this area may be of high priority for
intervention. Substantial regional and hospital type (teaching versus nonteaching) variability appears to
exist.
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P reventable medical complications related to medi-cation utilization and prescription have gainedgrowing national attention and are increasingly being targeted as areas for quality improvement.
1,2
An important group of patients in which these medical
complications can have dire consequences are those
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individuals 65 years of age and older. Because many
medications have prolonged half-lives in older adults,
the adverse effects of these agents can pose problems
long after patients have been discharged from the emer-
gency department (ED).3 Some medications dispropor-
tionately expose older adults to risk, as they lack efficacy
relative to their inherent side effects.4,5
The ED has been identified as a high-risk environ-
ment for adverse medication events and potentially
inappropriate medication (PIM) use in older adults, who
comprise the largest and fastest growing age group of
ED patients.6–8 Older adults make up less than 15% of
the U.S. population, but consume approximately one-
third of all prescription medications.9 This population is
growing rapidly, as are the numbers of medications
being prescribed to this age group. Previous research
has shown that the rate of PIM use by older adults in
ambulatory health settings is approximately 12.6%,
which represents 16 million people annually.10 Antihis-
tamines and narcotics have accounted for the majority
of inappropriate medications in prior studies. Several
recent studies have found even higher rates of inappro-
priate medication administration.8,11 The investigation
of more recent national trends in PIM use in EDs has
been limited and would provide meaningful information
regarding the current scope of this problem.
The primary goal of this study was to determine the
frequency of administration of PIMs to older adult ED
patients who were discharged to home. The secondary
objectives were to examine recent trends in the rates of
PIM usage and explore which patient, hospital, and
regional variables were associated with PIM utilization.
METHODS
Study Design
The National Hospital Ambulatory Medical Care Survey
(NHAMCS) was designed by the National Center for
Health Statistics (NCHS) and is administered by the
U.S. Census Bureau to measure utilization and provi-
sion of ambulatory care services at U.S. hospitals.
Using a four-stage probability sample design, NHAMCS
collects a nationally representative sample of all visits
to EDs based in noninstitutional general short-stay hos-
pitals, excluding federal, military, and Veterans Admin-
istration hospitals. Detailed descriptions of the methods
of NHAMCS have been previously published.12,13 The
University of Michigan Institutional Review Board
approved this study.
Study Sample
We restricted our population of interest to ED patients
from 2000 to 2006, aged 65 years and older, who were
discharged to home. Patients who were admitted to the
hospital, died in the ED, or left prior to examination or
against medical advice were not included. The survey
included a field for medications associated with the ED
visit. Although the current survey has data on up to
eight medications, surveys before 2003 only included
up to six, so this study concentrated on the first six
medication fields. Each medication in the database was
assigned an identification number in accordance to a
system designed by the NCHS.14 In addition, an indica-
tor was added in the later years of the study period to
distinguish between medications that were simply pre-
scribed, versus those that were actually administered
during the visit. As this indicator was not available for
all years, we did not utilize it as part of our analysis.
The Beers criteria were used to define PIMs and are
given in Appendix 1 (see Data Supplement S1, available
as supporting information in the online version of this
paper).5 Medications that were inappropriate only in
certain dosages, duration of administration, or comor-
bid conditions were not included in this study because
this information is not identifiable in NHAMCS-ED.
Therefore, the PIMs that were considered in our analy-
sis were medications that have been listed on the Beers
criteria independent of diagnosis or condition. We
applied the 2002 criteria to all years, although nifedi-
pine, clonidine, and ketorolac were added in that revi-
sion. Database management was conducted using SAS
Version 9.1.2 (SAS Institute, Inc., Cary, NC), and data
analysis was performed using STATA Version 10 (Stata-
Corp LP, College Station, TX).
Statistical Methods
Using the complex survey design of NHAMCS, esti-
mates of the proportion of subjects in the population of
interest (subpopulation) meeting the inclusion criteria
were calculated using sampling weights. To examine
the associations between demographic, hospital, pro-
vider, and visit characteristics we conducted bivariate
analyses using PIM association with an ED visit as a
dichotomous outcome (0 ⁄ 1). Chi-square tests of this
association were conducted for categorical variables.
Logistic regression was performed for continuous vari-
ables. We then conducted a multivariate analysis using
Hosmer and Lemeshow15 methodology. Continuous
variables that did not exhibit a linear relationship with
the logit were dichotomized. In addition, region of the
country was dichotomized for the models to facilitate
the investigation of interaction terms involving region
and urbanity. Year was considered as a continuous var-
iable to assess for temporal trends. Briefly, covariates
with a p < 0.25 were all entered into a preliminary main
effects model, all other covariates (those with p > 0.25
on bivariate analysis) were considered using forward
selection, and a priori considered interaction terms
were entered using forward selection to the previously
constructed model to produce the final model. Details
of the procedures and rationale utilized in model build-
ing are provided in Appendix 2 (see Data Supple-
ment S2, available as supporting information in the
online version of this paper). Model fit was assessed
using the svylogitgof function for complex survey data
as described by Archer and Lemeshow.16
Sensitivity Analyses
To assess whether considering the number of PIMs
associated with the visit as the outcome instead of the
dichotomous outcome used above substantially changed
the predictive model, we performed zero inflated Pois-
son regression using the same final model created
using binary logistic regression. We also examined the
rates of the three medications added to the Beers crite-
ria list in 2002 over the time period of this study.
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RESULTS
Between 2000 and 2006, the NHAMCS survey captured
a total of approximately 470,000 ED and outpatient
clinic visits, corresponding to a national estimate of
about 1.5 billion total ambulatory visits. Of these visits,
35,000 met our selection criteria of being 65 or older,
presenting to the ED, and being discharged to home
at the end of the visit. This provides a population esti-
mate of about 116 million ED visits from 2000 to 2006
for the sample of interest, whose characteristics are
given in Table 1. Nearly 75% (95% confidence interval
[CI] = 70.8% to 78.4%) of the sample of interest were
administered or prescribed at least one medication in
the ED.
From this sample of 35,000 visits, it was found that
5,926 visits were associated with at least one PIM. This
corresponds to a population estimate of 19,423,635
visits, or 16.8% (95% CI = 16.1% to 17.4%), associated
with at least one PIM between 2000 and 2006. The
frequency of PIM-associated visits by year is depicted
in Figure 1. Between 2000 and 2006, 13.25% (95% CI =
12.66% to 13.84%) received one PIM, 3.03% (95%
CI = 2.76% to 3.30%) received two PIMs, 0.45%
(95% CI = 0.35% to 0.55%) received three PIMs, and
0.04% (95% CI = 0.02% to 0.06%) received four PIMs.
No visit was associated with more than four PIMs.
While the rate of PIM-associated visits fluctuated from
year to year, the rate remained above 15% throughout
the study period. Table 2 lists the 10 most frequent PIMs
identified. The percentages reflect the total number of
PIMs administered to the population of interest as the
denominator, as some subjects received multiple PIMs.
The bivariate associations between variables of inter-
est and PIM use are reported in Table 3. The final logis-
tic regression model provides adjusted odds ratios
(ORs) for variables included in the model in Table 4.
The relationships between covariates involved in inter-
action terms included in the final model are given in
Figure 2. Younger women were more likely to have a
Table 1
Characteristics of Target Population (Discharged ED Patients Age
65 Years and Older)
Characteristics Mean 95% CI
Age (yr) 77.3 77.26–77.51
Sex
Female 68,266,450 (58.9) 58.2–59.6
Male 47,623,239 (41.1) 40.4–41.8
Race ⁄ ethnicity




Hispanic 19,366,269 (16.7) 14.6–18.8
Asian 2,004,111 (1.7) 1.2–2.3
Other 809,861 (0.7) 0.5–0.9
Health insurance
Medicare 86,745,631 (78.0) 76.8–79.1
Medicaid 8,139,515 (7.3) 6.5–8.1
Private 13501858 (12.1) 11.2–13.1
Self-pay 2,094,559 (1.9) 1.6–2.2
Other 787,334 (0.7) 0.6–0.9
Region
Northeast 25,182,718 (21.7) 19.4–24.0
Midwest 28,362,215 (24.5) 21.3–27.7
South 40,621,098 (35.1) 31.5–38.6
West 21,723,658 (18.8) 16.3–21.2
MSA 90,889,491 (78.4) 72.0–84.9
Non-MSA 25,000,198 (21.6) 15.1–28.0
Hospital ownership
Voluntary, nonprofit 89,031,694 (76.8) 73.8–79.8
Government, non-Federal 16,809,855 (14.5) 11.8–17.2
Proprietary 10,048,140 (8.7) 6.6–10.8
Seen by attending only 90,497,459 (78.1) 76.3–79.9
Seen by resident 10,429,755 (9.0) 7.8–10.2
Seen by midlevel provider 7,720,371 (6.7) 5.7–7.6
Immediacy
Immediate ⁄ no triage 19,631,809 (16.9) 14.9–19.0
Less than 15 minutes 31,049,887 (26.8) 25.0–28.5
15–60 minutes 42,201,238 (36.4) 34.8–38.0
>1–2 hours 16,025,846 (13.8) 12.7–15.0
>2–24 hours 6,980,909 (6.0) 5.3–6.8
Injury related visit 32,603,307 (28.1) 27.4–28.9
Total number of visit medications
0 29,407,762 (25.4) 24.3–26.5
1 29,424,573 (25.4) 24.6–26.2
2 21,774,332 (18.8) 18.2–19.4
3 12,936,491 (11.2) 10.7–11.6
4 7,845,784 (6.8) 6.3–7.2
5 4,586,968 (4.0) 3.6–4.3
6 9,913,779 (8.6) 7.4–9.7
Data are reported as mean or number (%). Estimates of
means and proportions of hospital, visit, and demographic
characteristics for all target population ED visits in U.S. from
2000–2006.
MSA = metropolitan statistical area.
Figure 1. Weighted proportion of target population receiving
potentially inappropriate medications (PIMs) by year.
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PIM-associated visit, as were rural visits outside of the
Northeast. Several variables were associated with PIM
administration, the strongest association of which was
receiving or being prescribed two or more medications
during an ED visit. Race and ethnicity were not associ-
ated with PIMs. Other visit characteristics associated
with PIM use included presenting with an injury or a
nonurgent complaint. Insurance status was not shown
to have a significant association with PIM use. Visits
occurring at for-profit hospitals were more likely to be
associated with a PIM. Having a resident or intern
involved in the visit was associated with a lower likeli-
hood of receiving a PIM. In the final model controlling
for the other covariates, the odds of receiving a PIM
decreased slightly for each additional year compared to
2000 with an OR of 0.98 (95% CI = 0.95 to 0.997).
For the first sensitivity analysis, the model was
repeated using zero-inflated Poisson regression. There
was no substantial change (i.e., the incidence rate ratios
did not differ from the logistic regression ORs by more
than 10%), and therefore only the results for the logistic
model are presented. When considering the utilization
of the three medications added to the Beers list in 2003
over our study period, no substantial change was
observed over time with a stable rate around 0.7% (see
Data Supplement S3, available as supporting informa-
tion in the online version of this paper).
DISCUSSION
Using a national sample of U.S. ED visits, we found that
a large proportion (nearly one in six visits) of older
adults discharged from the ED receive PIMs. Despite
the increased national attention to drug-related medical
complications, the total number of older adults receiv-
ing PIMs has been stable for over 6 years. This means
that almost 3 million ED visits by older adults each year
are estimated to be associated with PIM administration
or prescription. Our study found that older adults who
presented to EDs outside the Northeast, in nonaca-
demic hospitals, with an injury and with a less urgent
complaint were significantly more likely to receive a
PIM. The variability that exists between regions and
academic versus nonacademic hospitals is interesting. It
suggests that improvements may be occurring,
although with the persistently high rates of PIM usage
acceleration, wider implementation of efforts is likely to
be necessary.
Medications are a significant source of potential mor-
bidity and mortality in older patients. This is due to
physiologic changes that occur with aging, polyphar-
macy, and burden of chronic illnesses. Potentially inap-
propriate but commonly prescribed medications can
contribute to falls, altered mentation, and gastrointesti-
nal bleeding. Medication-induced complications in older
adults account for 7% to 11% of their visits to the ED,
and contribute to 12% to 17% of their hospital admis-
sions.12,17–21 These PIMs may negatively affect a
patient’s quality of life, as well as add unnecessary
health care costs to an already struggling U. S. health
care system.
Although the applicability of the Beers Criteria to the
ED has previously been questioned because they were
Table 2
Ten Most Commonly Administered Potentially Inappropriate





of Visits 95% CI
Promethazine 5,889,976 5.08 4.87–5.29
Ketorolac 3,696,537 3.19 3.03–3.35
Propoxyphene 3,043,306 2.63 2.50–2.75
Meperidine 2,785,735 2.40 2.26–2.55
Diphenhydramine 1,360,910 1.17 1.10–1.25
Clonidine 1,293,805 1.16 1.08–1.25
Hydroxyzine 930,219 0.82 0.76–0.88
Diazepam 898,733 0.78 0.72–0.84
Cyclobenzaprine 601,431 0.52 0.47–0.57
Nifedipine 405,871 0.35 0.31–0.39
Weighted estimate for total number (and percentage) of visits
associated with most common prescribed ⁄ administered
PIMs in the target population from 2000–2006.
Table 3
Bivariate Associations Between Patient, Hospital, and Visit
Variables and Use of PIMs
Variable OR 95% CI
Demographic variables
Age (75 and older vs. 65–74 yr) 1.30 1.23–1.37
Female (versus male) 1.39 1.31–1.48
Race ⁄ ethnicity (referent: white, non-Hispanic)
Asian 0.85 0.68–1.05






Private insurance 1.09 0.99–1.20
Self-pay 0.92 0.73–1.17
Hospital variables





Hospital owner (referent voluntary ⁄ nonprofit)
Proprietary 1.32 1.18–1.49
Government, non-Federal 1.17 1.03–1.33
Provider variables
Attending only 1.30 1.20–1.42
Resident present 0.69 0.61–0.78
Midlevel provider 1.00 0.88–1.14
Visit variables
Injury related visit 1.25 1.18–1.34
Year (1-yr change, i.e., 2002 vs. 2001) 0.98 0.96–1.00
Triage (referent: immediate ⁄ no triage)
Below 15 minutes 0.97 0.87–1.09
15–60 minutes 1.23 1.11–1.37
1–2 hours 1.37 1.21–1.56
2–24 hours 1.33 1.15–1.54
Prescribed or administered two
or more medications
6.62 6.15–7.14
MSA = metropolitan statistical area; PIM = potentially in-
appropriate medication.
The results of the individual bivariate associations between
clinical, demographic, provider, and hospital level variables
and prescription ⁄ administration of PIMs.
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initially constructed for other clinical settings (i.e.,
extended care facilities), the general principles of the
criteria are broadly applicable.22 The medications on
the list pose an unfavorable risk-to-benefit ratio in older
adults, and there are usually safer, more efficacious
medication alternatives available. Additionally, these
medications can potentially interact with routine medi-
cations being taken by older adults, compounding the
frequent administration of multiple medications during
a single ED visit.19,23,24 This study design did not
explore the possibility of medication interaction. This
may suggest we are currently underestimating the
potential harm. An argument that could be made is that
a single dose of a medication given in the ED is unlikely
to have a long-term deleterious effect. This may be the
case for certain medications such as ketorolac; how-
ever, for medications that affect cognition and balance,
a patient could experience a fall or respiratory arrest
after being sent home, and clearly such events could
be life-altering. While each PIM may not be inappropri-
ate in every administration or prescription to an older
adult sent home from the ED, given that alternatives
Table 4
Final Logistic Regression Model of Impact of Patient, Hospital, and Visit Characteristics
Parameter OR 95% CI Estimated Beta Standard Error p-value
Intercept )4.59 0.215 <0.001
Demographic covariates
Age less than 75 yr* 1.67 1.35–2.07 0.51 0.109 <0.001
Sex (female vs. male)* 1.56 1.39–1.75 0.45 0.059 <0.001
Hospital covariates
Region (rest of United States vs. Northeast)* 2.05 1.45–2.91 0.72 0.178 <0.001
Non-MSA vs. MSA* 1.35 1.17–1.57 0.30 0.075 <0.001
For profit hospital (vs. nonprofit or government) 1.19 1.03–1.38 0.17 0.074 0.017
Provider covariates
Seen with resident or intern involvement 0.65 0.55–0.76 )0.43 0.081 <0.001
Visit covariates
Visit due to injury 1.52 1.40–1.66 0.42 0.043 <0.001
Immediacy which should be seen (greater
than 1 hour vs. immediate)
1.44 1.29–1.61 0.37 0.055 <0.001
Received ⁄ prescribed two or more medications 6.99 6.31–7.73 1.94 0.052 <0.001
Timing
Year of visit (vs. 2000 per additional year) 0.98 0.95–0.997 )0.03 0.011 0.028
Interaction terms
Age · Sex interaction 0.16 0.077 0.037
Northeast · Urban interaction 0.23 0.151 0.119
Results of final logistic regression model that provide adjusted ORs for associations between variables of interest and PIM pres-
cription ⁄ administration. Main effects were considered for entry into the model if p < 0.25 and interaction terms were included
using forward selection with a criteria of p < 0.05 (see Data Supplement S2 for details). Total medications and age were initially
considered as continuous variables but did not have a linear relationship with the logit and were dichotomized. *ORs for covari-
ates involved in interactions are estimated assuming all other covariates are at the referent level. The Archer-Lemeshow good-
ness-of-fit statistic was 0.69 (p = 0.71).
MSA = metropolitan statistical area.
Figure 2. Predicted probabilities of potentially inappropriate medication (PIM) administration for covariates with interaction ([A]
sex and Age [yr]; [B] MSA and region) derived from final logistic regression model. All other covariates are considered to be at ref-
erent level and year 2000. MSA = metropolitan statistical area; PIM = potentially inappropriate medication.
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exist, it is likely that our method provides a reasonable
estimation of the scope of the problem using the exist-
ing criteria previously published by experts.
The current study found that 10 medications
accounted for 86.5% of PIMs used in the ED, of which
almost 40% was due to two medications—promethazine
and ketorolac. Thus, taking measures that concentrate
on eliminating the use of only a small number of medi-
cations could be very beneficial. The most frequently
identified PIMs fall into similar categories including
antihistamines, nonsteroidal anti-inflammatory drugs,
narcotics, and antihypertensives.
The problem of PIM use should be solvable at the
system level. Incorporating more safety measures such
as computer reviews or formulaic approaches, in addi-
tion to informing practitioners about the Beers criteria,
may dramatically decrease PIM administration to older
adults in the ED. The use of computer-aided real-time
decision support was effective in reducing PIM use in a
recent trial.25 In addition, updates of the Beers criteria
with the involvement of emergency physicians, or
development of new criteria specifically designed for
emergency medicine, could potentially be avenues for
future initiatives. Despite a lack of prior substantial
emergency medicine input and other limitations, the
Beers criteria certainly represent an important starting
point and are the most useful list of this sort that
currently exists.22
LIMITATIONS
Although there are circumstances in which medications
appearing on the Beers criteria are justified, more often
than not, the medications are still given at inappropri-
ate times. In one example, only an estimated 13% of vis-
its in which diazepam was administered were for
sprain, strain, fracture, or dislocation, which would rep-
resent potentially appropriate uses of the medication.10
As the number of potential indications for medications
is quite large, we did not attempt to relate the reason
for visit (except for injury) or diagnosis to the medica-
tion use. This is a limitation in NHAMCS, given that rel-
atively few sampled visits are occurring for each
medication. We also could not identify whether a medi-
cation was given in the ED or if it was prescribed
for the patient to take at home. However, because
NHAMCS has changed its data collection process,
future analyses of these data starting in 2003 will be
able to separate out medication administration in the
ED versus prescription. An additional limitation is the
restriction of our analysis to the first six medication
fields to ensure consistency throughout our analysis.
This would tend to lead to an underestimation of PIM
associated visits. A further limitation of this study is
that the NHAMCS survey does not provide any infor-
mation regarding whether the PIM actually led to an
adverse event. However, prior work has shown com-
pelling associations between PIM use and medication-
related problems and hospitalizations in older
adults.18,21,26–28 It is reasonable to conclude that while
PIMs are not inevitably going to cause problems for
each individual patient, they place the patient at a
higher risk for having an adverse event, and that risk-
to-benefit ratio becomes unfavorable to an older adult
when there are alternative medications. Finally, other
adverse events associated with medications and medi-
cation interactions are not addressed by this study
design, but would be useful areas for further study.
CONCLUSIONS
Approximately 3 million older adults in the United
States each year are receiving or being prescribed at
least one potentially inappropriate medication in the
ED. This high number demonstrates that the abundant
literature expressing the risks of prescribing older
adults certain medications has not translated into
reductions in the large numbers of older adults receiv-
ing potentially inappropriate medications in the ED. It
is necessary to encourage ED caregivers to review the
safety concerns associated with potentially inappropri-
ate medication prescription and administration, espe-
cially when polypharmacy is involved. Eliminating the
use of the top two drugs alone would reduce the
amount of potentially inappropriate medication admin-
istration by 40%. As preventable errors and complica-
tions of medical care are increasingly becoming
intolerable to payers and society, reducing the use of
certain medications in older adults should be a focus in
the efforts to optimize patient outcomes.
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